GAR-936 (9-t-butylglycylamido-minocycline) susceptibility test development for streptococci, Haemophilus influenzae and Neisseria gonorrhoeae: preliminary guidelines and interpretive criteria
- 13 July 2001
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 18 (1), 29-35
- https://doi.org/10.1016/s0924-8579(01)00355-7
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Antipneumococcal Activities of GAR-936 (a New Glycylcycline) Compared to Those of Nine Other Agents against Penicillin-Susceptible and -Resistant PneumococciAntimicrobial Agents and Chemotherapy, 2000
- The impact of antimicrobial resistance: changing epidemiology of community-acquired respiratory-tract infectionsAmerican Journal of Health-System Pharmacy, 1999
- Disk diffusion susceptibility test development for the new glycylcycline, GAR-936Diagnostic Microbiology and Infectious Disease, 1999
- Prevalence of Antimicrobial Resistance Among Respiratory Tract Isolates ofStreptococcus pneumoniaein North America: 1997 Results from the SENTRY Antimicrobial Surveillance ProgramClinical Infectious Diseases, 1998
- Susceptibilities of Neisseria gonorrhoeae to the glycylcyclinesAntimicrobial Agents and Chemotherapy, 1995
- In vitro activities of two glycylcyclinesAntimicrobial Agents and Chemotherapy, 1994
- In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclinesAntimicrobial Agents and Chemotherapy, 1993
- Treatment and Diagnosis of Infections Caused by Drug-Resistant Streptococcus pneumoniaeClinical Infectious Diseases, 1992
- Tetracyclines, molecular and clinical aspectsJournal of Antimicrobial Chemotherapy, 1992
- Doxycycline and minocycline in the treatment of respiratory infections: a double-blind comparative clinical, microbiological and pharmacokinetic studyJournal of Antimicrobial Chemotherapy, 1989